Back to Search

JEEVANA SREEJA AMBATI, M.D.

M.D.

Endocrinology, Diabetes & Metabolism Physician

NPI: 1649849050Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

4351048555(MI)
Endocrinology, Diabetes & Metabolism PhysicianPrimary

Internal Medicine — Endocrinology, Diabetes & Metabolism

Code: 207RE0101X

125-084109(IL)
Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (20)

Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.
PMID 19359485·Proc Natl Acad Sci U S A·2009
7-preclinical
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.
PMID 19668192·Nat Med·2009
7-preclinical
CCR3 is a target for age-related macular degeneration diagnosis and therapy.
PMID 19525930·Nature·2009
7-preclinical
Fifty years later: the disk goes to the prom.
PMID 18654671·J Clin Invest·2008
7-preclinical
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
PMID 18368052·Nature·2008
7-preclinical
Toward a higher fidelity model of AMD.
PMID 18188944·Adv Exp Med Biol·2008
7-preclinical
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.
PMID 18922791·J Biol Chem·2008
7-preclinical
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.
PMID 18753640·N Engl J Med·2008
4-observational
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein.
PMID 17560152·J Mol Graph Model·2007
8-other
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization.
PMID 17198016·Cornea·2007
7-preclinical
Corneal avascularity is due to soluble VEGF receptor-1.
PMID 17051153·Nature·2006
7-preclinical
CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.
PMID 16831471·J Neuroimmunol·2006
7-preclinical
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
PMID 16453023·J Clin Invest·2006
7-preclinical
Drusen complement components C3a and C5a promote choroidal neovascularization.
PMID 16452172·Proc Natl Acad Sci U S A·2006
7-preclinical
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
PMID 16206161·Glia·2006
7-preclinical
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo.
PMID 15851564·Invest Ophthalmol Vis Sci·2005
7-preclinical
Eyelid disease.
PMID 16271321·Ophthalmology·2005
8-other
Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization.
PMID 15896317·Biochem Biophys Res Commun·2005
7-preclinical
Aquaporin-1 expression is decreased in human and mouse corneal endothelial dysfunction.
PMID 14758337·Mol Vis·2004
7-preclinical
Retinoblastoma with cataract and ectopia lentis.
PMID 14730297·J AAPOS·2003
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
751 N RUTLEDGE, SUITE 1700
SPRINGFIELD, IL 62702

Location

Practice Location

751 N RUTLEDGE, SPRINGFIELD, IL
(217) 545-0166

Quick Facts

NPI
1649849050
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
20

Are you this provider?

Claim Your Profile